Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer beat Wall ​Street estimates for ‌second-quarter profit on Tuesday, ​driven by ​strong demand for ⁠its blood ​thinner, Eliquis.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。